These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38163747)

  • 1. Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo.
    Zola Matuvanga T; Larivière Y; Lemey G; Isekah Osang'ir B; Mariën J; Milolo S; Meta R; Matangila J; Maketa V; Mitashi P; Van Geertruyden JP; Muhindo-Mavoko H; Van Damme P
    Vaccine; 2024 Jan; 42(3):481-488. PubMed ID: 38163747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
    Larivière Y; Zola T; Stoppie E; Maketa V; Matangila J; Mitashi P; De Bie J; Muhindo-Mavoko H; Van Geertruyden JP; Van Damme P
    BMJ Open; 2021 Sep; 11(9):e046835. PubMed ID: 34588237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
    Larivière Y; Matuvanga TZ; Lemey G; Osang'ir BI; Vermeiren PP; Milolo S; Meta R; Kimbulu P; Esanga E; Matangila J; Van Geertruyden JP; Van Damme P; Maketa V; Muhindo-Mavoko H; Mitashi P
    Vaccine; 2023 Dec; 41(51):7587-7597. PubMed ID: 37993355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
    Zola Matuvanga T; Mariën J; Larivière Y; Osang'ir BI; Milolo S; Meta R; Esanga E; Maketa V; Matangila J; Mitashi P; Ahuka Mundeke S; Muhindo-Mavoko H; Muyembe Tamfum JJ; Van Damme P; Van Geertruyden JP
    PLoS One; 2023; 18(9):e0286479. PubMed ID: 37656725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study.
    Zola Matuvanga T; Johnson G; Larivière Y; Esanga Longomo E; Matangila J; Maketa V; Lapika B; Mitashi P; Mc Kenna P; De Bie J; Van Geertruyden JP; Van Damme P; Muhindo Mavoko H
    J Med Internet Res; 2021 Aug; 23(8):e28573. PubMed ID: 34378545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
    Watson-Jones D; Kavunga-Membo H; Grais RF; Ahuka S; Roberts N; Edmunds WJ; Choi EM; Roberts CH; Edwards T; Camacho A; Lees S; Leyssen M; Spiessens B; Luhn K; Douoguih M; Hatchett R; Bausch DG; Muyembe JJ;
    BMJ Open; 2022 Mar; 12(3):e055596. PubMed ID: 35260458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
    Zola Matuvanga T; Larivière Y; Lemey G; De Bie J; Milolo S; Meta R; Esanga E; Vermeiren PP; Thys S; Van Geertruyden JP; Van Damme P; Maketa V; Matangila J; Mitashi P; Muhindo-Mavoko H
    Vaccine; 2022 May; 40(25):3470-3480. PubMed ID: 35550847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection, health seeking, or a laissez-passer: Participants' decision-making in an EVD vaccine trial in the eastern Democratic Republic of the Congo.
    James M; Kasereka JG; Kasiwa B; Kavunga-Membo H; Kambale K; Grais R; Muyembe-Tamfum JJ; Bausch DG; Watson-Jones D; Lees S
    Soc Sci Med; 2023 Apr; 323():115833. PubMed ID: 36934528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Are You Sure It's Not the Corona Vaccine?" An Ebola Vaccine Trial During COVID-19 in DRC.
    James MV; Lees SS
    Med Anthropol; 2022 Aug; 41(5):503-517. PubMed ID: 35838298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and practices of seeking informed consent for medical examinations and procedures by health workers in the Democratic Republic of Congo.
    Nzaumvila D; Ntotolo P; Govender I; Lukanu P; Niati JL; Sanduku D; Bongongo T
    Afr Health Sci; 2021 Mar; 21(1):478-488. PubMed ID: 34394330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo.
    Lemey G; Larivière Y; Zola TM; Maketa V; Matangila J; Mitashi P; Vermeiren P; Thys S; De Bie J; Muhindo HM; Ravinetto R; Van Damme P; Van Geertruyden JP
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34183329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Providers' and Frontline Workers' Experiences of an Ebola Vaccine Trial in the Boende Health District of the Democratic Republic of the Congo.
    Zola Matuvanga T; Bolombo FB; Paviotti A; Larivière Y; Lemey G; Salloum M; Osang'ir BI; Matangila J; Maketa V; Esanga E; Milolo S; Mitashi P; Van Damme P; Muhindo-Mavoko H; Van Geertruyden JP
    Am J Trop Med Hyg; 2024 Sep; 111(3):578-588. PubMed ID: 38955200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
    Jalloh MF; Jalloh MB; Albert A; Wolff B; Callis A; Ramakrishnan A; Cramer E; Sengeh P; Pratt SA; Conteh L; Hajjeh R; Bunnell R; Redd JT; Ekström AM; Nordenstedt H
    Vaccine; 2019 Mar; 37(11):1495-1502. PubMed ID: 30755367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations.
    Lemey G; Larivière Y; Osang'ir BI; Zola T; Kimbulu P; Milolo S; Danoff E; Tchuma Y; Maketa V; Mitashi P; Ravinetto R; Van Damme P; Van Geertruyden JP; Muhindo-Mavoko H
    BMJ Glob Health; 2024 Jun; 9(6):. PubMed ID: 38857947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and factors associated among caregivers of adolescent and young adult Ebola survivors in Democratic Republic of the Congo, a cross-sectional study.
    Munyumu K; Wafula C; Were V; Katungu F; Mbasa N; Kaseje M
    BMC Public Health; 2023 Nov; 23(1):2362. PubMed ID: 38031082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
    Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; Chêne G; Beavogui AH; Richert L;
    Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under consent: participation of people with HIV in an Ebola vaccine trial in Canada.
    David PM; Mathiot B; Thiongane O; Graham JE
    BMC Med Ethics; 2021 Apr; 22(1):42. PubMed ID: 33836725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola vaccination in the Democratic Republic of the Congo.
    Wells CR; Pandey A; Parpia AS; Fitzpatrick MC; Meyers LA; Singer BH; Galvani AP
    Proc Natl Acad Sci U S A; 2019 May; 116(20):10178-10183. PubMed ID: 31036657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plan to use second Ebola vaccine sparks debate.
    Kupferschmidt K
    Science; 2019 Jun; 364(6447):1221. PubMed ID: 31249040
    [No Abstract]   [Full Text] [Related]  

  • 20. Ebola Virus in the Democratic Republic of the Congo: Advances and Remaining Obstacles in Epidemic Control, Clinical Care, and Biomedical Research.
    Erb-Alvarez J; Wendelboe AM; Chertow DS
    Chest; 2020 Jan; 157(1):42-46. PubMed ID: 31518557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.